The Biden-Harris administration yesterday sent Congress its first-year drug policy priorities, as required by each new administration. 

They call for expanding access to evidence-based treatment; advancing racial equity in drug policy; enhancing evidence-based efforts to reduce harm; supporting evidence-based efforts to prevent youth substance use; reducing the supply of illicit substances; removing barriers to employment for people in recovery and expanding the addiction workforce; and expanding access to recovery support services.
 

Related News Articles

Perspective
Public
Congress returned to Washington this week with a full plate of issues to contend with in the short-term as it defines its legislative agenda for the remainder…
Headline
The House Energy and Commerce Subcommittee on Health held a hearing Jan. 8 to discuss legislation on Medicare payment policies for seniors, including the AHA-…
Chairperson's File
Public
One of the most rewarding parts of being an AHA member and serving on the board is building relationships with other leaders who share a passion for making…
Headline
The AHA Dec. 11 expressed support for the reintroduction of the Future Advancement of Academic Nursing, bicameral legislation that would increase nursing…
Headline
The Centers for Medicare & Medicaid Services released guidance Dec. 8 for states implementing Medicaid community engagement requirements outlined by the…
Chairperson's File
Public
For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…